Drugs

Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens
Alessandro Invernizzi, Francesco Pichi, Richard Symes, Sophia Zagora, Aniruddha Kishandutt Agarwal, Phuc Nguyen, Stefano Erba, Alba Xhepa, Luca De Simone, Luca Cimino, Mark C Gillies, Peter J McCluskey

British Journal of Ophthalmology Nov 2019, bjophthalmol-2019-315257; DOI: 10.1136/bjophthalmol-2019-315257
Safety of 6000 intravitreal dexamethasone implants
Bindu Rajesh, Javier Zarranz-Ventura, Adrian T Fung, Catharina Busch, Niroj Kumar Sahoo, Patricio J Rodriguez-Valdes, Valentina Sarao, Sanjay Kumar Mishra, A Osman Saatci, Patricia Udaondo Mirete, Giuseppe Querques, Michel Eid Farah, Paolo Lanzetta, J Fernando Arevalo, Laurent Kodjikian, Jay Chhablani

British Journal of Ophthalmology Jan 2020, 104 (1) 39-46; DOI: 10.1136/bjophthalmol-2019-313991
Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort
Nieraj Jain, Alexa L Li, Yinxi Yu, Brian L VanderBeek

British Journal of Ophthalmology Nov 2019, bjophthalmol-2019-314765; DOI: 10.1136/bjophthalmol-2019-314765
Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)—study protocol
Augusto Azuara-Blanco, Nicola Logan, Niall Strang, Kathryn Saunders, Peter M Allen, Ruth Weir, Paul Doherty, Catherine Adams, Evie Gardner, Ruth Hogg, Margaret McFarland, Jennifer Preston, Rejina Verghis, James J Loughman, Ian Flitcroft, David A Mackey, Samantha Sze-Yee Lee, Christopher Hammond, Nathan Congdon, Mike Clarke

British Journal of Ophthalmology Oct 2019, bjophthalmol-2019-314819; DOI: 10.1136/bjophthalmol-2019-314819
ACE inhibitor use and risk of cataract: a case–control analysis
Claudia Becker, Susan S Jick, Christoph R Meier

British Journal of Ophthalmology Nov 2019, 103 (11) 1561-1565; DOI: 10.1136/bjophthalmol-2018-312980
Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects
Sean T Garrity, Joo Yeon Jung, Olivia Zambrowski, Francesco Pichi, Daniel Su, Malvika Arya, Nadia K Waheed, Jay S Duker, Yaïr Chetrit, Elisabetta Miserocchi, Chiara Giuffrè, Talia R Kaden, Giuseppe Querques, Eric H Souied, K Bailey Freund, David Sarraf

British Journal of Ophthalmology Nov 2019, 103 (11) 1600-1604; DOI: 10.1136/bjophthalmol-2018-313350
Adalimumab for non-infectious uveitis: is it cost-effective?
Inigo Bermejo, Hazel Squires, Edith N Poku, Katy Cooper, John W Stevens, Jean Hamilton, Ruth Wong, Ian Pearce, Fahd Mohammed Quhill, Alastair K Denniston

British Journal of Ophthalmology Nov 2019, 103 (11) 1633-1638; DOI: 10.1136/bjophthalmol-2018-312756
Current and emerging pharmaceutical interventions for myopia
Kritchai Vutipongsatorn, Tae Yokoi, Kyoko Ohno-Matsui

British Journal of Ophthalmology Nov 2019, 103 (11) 1539-1548; DOI: 10.1136/bjophthalmol-2018-313798
Posterior segment drug delivery for the treatment of exudative age-related macular degeneration and diabetic macular oedema
Chee Wai Wong, Tina T Wong

British Journal of Ophthalmology Oct 2019, 103 (10) 1356-1360; DOI: 10.1136/bjophthalmol-2018-313462
Local therapy for cancer therapy-associated uveitis: a case series and review of the literature
Arthi Ganesh Venkat, Sruthi Arepalli, Sumit Sharma, Naveen Karthik, Careen Lowder, Justis P Ehlers, Arun Singh, Jeffrey Goshe, Sunil Srivastava

British Journal of Ophthalmology Aug 2019, bjophthalmol-2019-314403; DOI: 10.1136/bjophthalmol-2019-314403

Main menu

Drugs

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Drugs

Pages